Back to search

University of Thessaly (UTH)

Μελέτη της σχέσης της οδού των νευροπεπτιδίων και της ενδοκυττάριας στεροειδογένεσης στον καρκίνο του προστάτη

Abstract

dc:description

Abiraterone is an androgen biosynthesis inhibitor that selectively inhibits the enzyme CYP17 (17α- Hydroxylase and C17,20 -lyase) irreversibly. These CYP17 enzymes are required for the synthesis of testosterone in the body. Neuropeptides, like endothelin-1 (ET-1) and growth factors like Fibroblast Growth Factor -2 (FGF-2) and Hepatocyte Growth Factor (HGF) exist in high levels in prostate cancer cells and each factor individually has shown to contribute in the development and progression of prostate cancer. The aim of this study is to investigate whether the intracellular steroidogenesis triggered by ET-1, FGF-2 or HGF acts as a resistant mechanism in abiraterone’s action in prostate cancer. In this research, LNCaP and PC3 cells were used as in vitro models of androgen dependent (AD) (LNCaP) and androgen independent (AI) (PC3) prostate cancer. Cells were incubated with ET-1, FGF-2, HGF and/or abiraterone for 24 hours. After the period of 24 hours, the intracellular levels of 17-OH progesterone and dihydrotestosterone (DHT) were determined by ELISA method, proliferation rate was determined with MTT method and the expression of akt/p-akt, p-S6RP and p70S6 proteins was determined with Western Blot. According to our results, ET-1 has a regulatory role in steroidogenesis by mainly increasing the intracellular levels of DHT in PC3 cells but has no significant effect in the proliferation rate of both PC3 and LNCaP cells. The presence of different concentrations of abiraterone showed a decrease in intracellular levels of DHT in PC3 and LNCaP cells. Regarding the proliferation rate, LNCaP cells showed statistically significant decreases in proliferation in a dose-dependent way with all abiraterone concentrations that were used. Furthermore, PC3 cells showed a reduction in proliferation rate only when the highest concentration of abiraterone was used. Our findings highlight for the first time that abiraterone seems to have a pre-dominant role in the inhibition of cell proliferation and not only in the inhibition of steroidogenesis. Furthermore, with the experiments of co-administration of ET-1 and abiraterone, it was shown that ET-1 acts as an escape mechanism in abiraterone’s action via the increase of DHT levels. Additionally, abiraterone uses PI3Κ/akt pathway to inhibit cell proliferation in the presence of ET-1. Moreover, in the next steps of our research FGF-2 and HGF were found to decrease the intracellular levels of 17-OH progesterone in both cell lines, whereas HGF alone found to increase the intracellular levels of DHT only in PC3 cells. Interestingly however, the simultaneous exposure of cells to abiraterone and FGF-2 or HGF while it does not result to changes in the intracellular levels of 17-OH progesterone, found to result to increased intracellular levels of DHT. These findings suggest for the first time that ET-1, FGF-2 and HGF may act as escape mechanisms aiding the development of resistance to abiraterone. Their action by restoring intratumoral androgen synthesis in tumor environment may contribute to disease progression.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vasileiou, Chrysoula
  • Βασιλείου, Χρυσούλα

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47405

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vasileiou, Chrysoula; Βασιλείου, Χρυσούλα. Μελέτη της σχέσης της οδού των νευροπεπτιδίων και της ενδοκυττάριας στεροειδογένεσης στον καρκίνο του προστάτη. University of Thessaly (UTH), 2020. http://hdl.handle.net/10442/hedi/47405